Previous
Next

DYANAVEL XR is a central nervous system stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). DYANAVEL XR is a tablet that can be swallowed whole or chewed.

It is not known if DYANAVEL XR is safe and effective in children under 6 years of age.

DYANAVEL XR is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else, because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

Unique Technology: Consistent control

If you feel like your ADHD medication isn't lasting as long as you need it to, DYANAVEL XR (amphetamine) may be an option that's right for you!

Watch our Technology Video Read this quick guide to DYANAVEL XR

Continuous Icon

Continuous

Smooth release of amphetamine through the day2,3

Medication Action
Predictable Icon

Proven

ADHD symptom control for 13 hours1

Study Results
Flexible Dosing Icon

Flexible dosing

Tablets can be swallowed or chewed4

Dosing Options
DXRT ADHD savings support guaranteed availability

We want to make getting DYANAVEL XR as easy and inexpensive as possible! Learn about your options below!

DYANAVEL Delivered Program

perigon logo

Fill your prescription through DYANAVEL Delivered for guaranteed availability!

Free, fast delivery, full patient support, and the lowest available price:

$25 for commercially-insured patients with DYANAVEL coverage*

$100 for patients who choose to pay cash*

Info for new patients
Info for current patients

Savings Program

Dyanavel XR ADHD Savings Card

Fill your prescription at your local pharmacy and save!

Eligible patients pay $25* per month with the DYANAVEL XR Savings Program

Get savings card

Or text TRIS to TRIS4U (874748) for a Mobile Savings Card.**

ADHD in adults isn’t just about work or school — it can cause symptoms throughout the day and into the evening, affecting different areas of your life5

If you need your ADHD medication to work consistently—through the day, every day—DYANAVEL XR may be able to help.

Tris DXRT Brochure
Patient Brochure

Spanish Patient Brochure

PATIENT Stories

Note: Qualified candidates will be compensated for their involvement and time; not all candidates will be selected to participate.

Perigon Pharmacy 360 works directly with Tris Pharma to ensure DYANAVEL XR tablets are always available.

*Co-pay offer is subject to eligibility. Terms and Conditions apply.

** Mobile Terms and Conditions: coupon.trisadhd.com/terms. Message data rates may apply.

References: 1. Childress AC, Wigal SB, Brams MN, et al. Efficacy and safety of amphetamine extended-release oral suspension in children with attentiondeficit/hyperactivity disorder. J Child Adolesc Psycholpharmacol. 2018;28(5):306-313. 2. Pardo A, Kando JC, King TR, Rafla E, Herman BK. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectr. 2020;25(6):774-781. 3. Kando JC, King TR, Pardo A. A novel, modified release drug delivery technology containing amphetamine and methylphenidate ion-exchange complexes. Poster presented at: American Psychiatric Association Annual Meeting; May 1-3, 2021. 4. Dyanavel XR [package insert]. Tris Pharma, Inc., Monmouth Junction, NJ. 5. Jain R. Addressing diagnosis and treatment gaps in adults with attentiondeficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2017;19(5):17nr02153. 6. Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. US Department of Health and Human Services. Centers for Disease Control and Prevention. MMWR. October 10, 2024. Vol. 73, No. 40.

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

See Additional Important Safety Information.

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

Your healthcare provider should check you or your child's risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR and will monitor you or your child during treatment.

Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol prescription medicines, or street drugs.

DYANAVEL XR should not be taken if you or your child are allergic to amphetamine or any of the ingredients in DYANAVEL XR or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI including the antibiotic linezolid and the intravenous medicine methylene blue.

DYANAVEL XR can cause serious side effects including:

  • Risks for people with serious heart disease: Sudden death has happened in people who have heart defects or other serious heart disease. Before starting DYANAVEL XR, tell your healthcare provider if you or your child have any heart problems, heart disease, or heart defects.
    Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting during treatment with DYANAVEL XR.
  • Increase in blood pressure and heart rate.
    Your healthcare provider should check your or your child’s blood pressure and heart rate regularly during treatment with DYANAVEL XR.
  • Mental (psychiatric) problems, including new or worse behavior and thought problems, new or worse bipolar illness, new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms.
    Tell your healthcare provider about any mental problems you or your child have, or about a family history of suicide, bipolar illness, or depression. Call the doctor right away if there are any new or worsening mental symptoms during treatment.
  • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Tell your healthcare provider if you or your child have numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes.
    Call the doctor right away if you or your child have any signs of unexplained wounds appearing on fingers or toes during treatment with DYANAVEL XR.
  • New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare provider if you or your child get any new or worsening tics or worsening Tourette’s syndrome during treatment with DYANAVEL XR.
  • Serotonin Syndrome. This problem may happen when DYANAVEL XR is taken with certain other medicines and may be life-threatening. Stop taking DYANAVEL XR and call your healthcare provider or go to the nearest hospital emergency room if you get symptoms such as agitation, hallucinations, coma, or other changes in mental status; fast heartbeat; sweating or fever; nausea, vomiting, diarrhea; high or low blood pressure; problems controlling movements or muscle twitching; muscle stiffness or tightness.
  • Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment with DYANAVEL XR. Your healthcare provider may stop your child’s DYANAVEL XR treatment if they are not growing or gaining weight as expected.
  • It is not known if DYANAVEL XR will harm the unborn baby. There is a pregnancy registry for females who are exposed to DYANAVEL XR during pregnancy. The purpose of the registry is to collect information about the health of females exposed to DYANAVEL XR and their baby. If you or your child becomes pregnant during treatment with DYANAVEL XR, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants at 1-866-961-2388 or visit https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/.
  • DYANAVEL XR passes into breast milk. You or your child should not breastfeed during treatment with DYANAVEL XR. Tell your doctor if you are breastfeeding or plan to breastfeed.
  • The most common side effects of amphetamine products include:

    – dry mouth

    – decreased appetite

    – weight loss

    – stomach pain

    – nausea

    – trouble sleeping

    – restlessness

    – extreme mood changes

    – dizziness

    – increased heart rate

Talk to your doctor if you or your child have any side effects that bother you or do not go away.
Avoid drinking alcohol while taking DYANAVEL XR.

To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Please see Full Prescribing Information, including Boxed Warning about Abuse, Misuse and Addiction and Medication Guide.

up arrowTop